Evommune (EVMN) Invested Capital (2024 - 2026)
Evommune (EVMN) reported Invested Capital of $304.6 million for Q1 2026, up 292.47% year-over-year from $77.6 million in Q1 2025, and up 48.15% quarter-over-quarter from $205.6 million in Q4 2025.
Evommune (EVMN) Invested Capital (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of Invested Capital data on file, last reported at $304.6 million in Q1 2026.
- Invested Capital for Q1 2026 came in at $304.6 million, up 292.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $304.6 million (up 292.47% YoY), and the FY2025 annual result was $205.6 million, up 242.52% from the prior year.
- Invested Capital improved to $304.6 million in Q1 2026 per EVMN's latest filing, from $205.6 million in the prior quarter.
- Over five years, Invested Capital peaked at $304.6 million in Q1 2026 and troughed at -$183.1 million in Q3 2025.
- A 3-year average of -$16.3 million and a median of -$133.4 million in 2024 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2025 and 2026: Invested Capital plunged 49.47% in 2025, then jumped 292.47% in 2026.
- A 3-year view of Invested Capital shows it stood at -$144.2 million in 2024, then jumped by 242.52% to $205.6 million in 2025, then surged by 48.15% to $304.6 million in 2026.
- Business Quant data shows EVMN's Invested Capital at $304.6 million in Q1 2026, $205.6 million in Q4 2025, and -$183.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | Evommune | 695.29 Mn | 483.82 Mn | - | 304.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 304.56 Mn |
| Dec 31, 2025 | 205.57 Mn |
| Sep 30, 2025 | -183.14 Mn |
| Mar 31, 2025 | -158.24 Mn |
| Dec 31, 2024 | -144.24 Mn |
| Sep 30, 2024 | -122.53 Mn |